Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1562-1571

  Luo, Hong ^a,b   Rose, Paul ^a   Barber, Dwayne ^a,d   Hanratty, William P ^c   Lee, Sue ^a   Roberts, Thomas M ^a   D'Andrea, Alan D ^a   Dearolf, Charles R ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTAMIC ACID; LYSINE; POLYADENYLATED RNA; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CELL LINE; DNA SEQUENCE; DROSOPHILA; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENE MUTATION; HEMATOPOIESIS; MOLECULAR CLONING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE CULTURE;

ANIMALIA; DROSOPHILA MELANOGASTER; HUMULUS; JANUS; MAMMALIA; MELANOGASTER; MURINAE;

EID: 0031017533     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.3.1562     Document Type: Article

References (53)

1. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
2. Argetsinger, L. S., G. S. Campbell, X. Yang, B. A. Witthuhn, O. Silvennoinen, J. N. Ihle, and C. Carter-Su. 1993. Identification of Jak2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244.
3. Argetsinger, L. S., G. W. Hsu, M. G. Myers, Jr., N. Billestrup, M. F. White, and C. Carter-Su. 1995. Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270:14685-14692.
4. Azam, M., H. Erdjument-Bromage, B. L. Kreider, M. Xia, F. Quelle, R. Basu, C. Saris, P. Tempst, J. N. Ihle, and C. Schindler. 1995. Inlerleukin-3 signals through multiple isoforms of Stat5. EMBO J. 14:1402-1411.
5. Barber, D. L., J. C. DeMartino, M. O. Showers, and A. D. D'Andrea. 1994. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Mol. Cell. Biol. 14:2257-2265.
6. Barber, D. L., B. K. Beattie, A. D. D'Andrea, and D. A. Frank. 1996. An activation-specific Stat5 antibody selectively recognizes the tyrosine phosphorylated forms of the erythropoietin receptor and Stat5. Blood 88:53a.
7. Binari, R., and N. Perrimon. 1994. Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev. 8:300-312.
8. Chinkers, M., and D. L. Garbers. 1989. The protein kinase domain of the ANP receptor is required for signaling. Science 245:1392-1394.
9. Darnell, J. E., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1420.
10. b3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesis. Dev. Biol. 129:159-168.
11. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450.
12. Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42-52.
13. Hanratty, W. P., and C. R. Dearolf. 1993. The Drosophila Tumorous-lethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol. Gen. Genet. 238:33-37.
14. Hanratty, W. P., and J. S. Ryerse. 1981. A genetic melanotic neoplasm of Drosophila melanogaster. Dev. Biol. 83:238-249.
15. Harpur, A. G., A.-C. Andres, A. Ziemiecki, R. R. Aston, and A. F. Wilks. 1992. JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 7:1347-1353.
16. Harrison, D. A., R. Binari, T. S. Nahreini, M. Gilman, and N. Perrimon. 1995. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 14:2857-2865.
17. He, T.-C., N. Jiang, H. Zhuang, and D. M. Wojchowski. 1995. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway. J. Biol. Chem. 270:11055-11061.
18. Hou, X. S., M. B. Melnick, and N. Perrimon. 1996. marelle acts downstream of the Drosophila HOP/JAK kinase and encodes a protein similar to the mammalian STATs. Cell 84:411-419.
19. Humason, G. L. 1972. Animal tissue techniques, 3rd ed. Freeman, San Francisco, Calif.
20. Ihle, J. N. 1995. Cytokine receptor signaling. Nature 377:591-594.
21. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334.
22. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313-319.
23. Klingermuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of Jak2 and termination of proliferative signals. Cell 80:729-738.
24. Krasnow, M. A., E. E. Saffman, K. Kornfeld, and D. S. Hogness. 1989. Transcriptional activation and repression by ultrabithorax proteins in cultured Drosophila cells. Cell 57:1031-1043.
25. Levy, D. E., D. S. Kessler, R. I. Pine, and J. E. Darnell, Jr. 1989. Cytoplasmic activation of ISGF3, the positive regulator of interferon-α stimulated transcription, reconstituted in vitro. Genes Dev. 3:1362-1372.
26. Lewis, E. B., and F. Bacher. 1968. Methods of feeding ethyl methane sulfonate (EMS) to Drosophila males. Drosophila Inf. Serv. 43:193.
27. Lindsley, D. L., and G. G. Zimm. 1992. The genome of Drosophila melanogaster. Academic Press, San Diego, Calif.
28. Tum-l Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 14:1412-1420.
29. Luo, H., and C. Dearolf. Unpublished observations.
30. Macchi, P., A. Villa, S. Giliani, M. G. Sacco, A. Frattini, F. Porta, A. G. Ugazio, J. A. Johnston, F. Candotti, J. J. O'Shea, P. Vezzoni, and L. D. Notarangelo. 1995. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-68.
31. Meraz, M. A., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the stat1 gene in mice reveals unexpected physiologic specificity in the Jak-Stat signaling pathway. Cell 84:431-442.
32. Meydan, N., T. Grunberger, H. Dadi, M. Shahar, E. Arpaia, Z. Lapidot, J. S. Leeder, M. Freedman, A. Cohen, A. Gazit, A. Levitzki, and C. M. Roifman. 1996. Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 379:645-648.
33. Miura, O., N. Nakamura, J. N. Ihle, and N. Aoki. 1994. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J. Biol. Chem. 269:614-620.
34. Nappi, A. J., and M. Silvers. 1984. Cell surface changes associated with cellular immune reactions in Drosophila. Science 225:1166-1168.
35. Nosaka, T., J. M. A. van Deursen, R. A. Tripp, W. E. Thierfelder, B. A. Witthuhn, A. P. McMickle, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1995. Defective lymphoid development in mice lacking Jak3. Science 270: 800-802.
36. Perrimon, N., and A. P. Mahowald. 1986. 1(1)hopscotch, a larval-pupal zygotic lethal with a specific maternal effect on segmentation in Drosophila. Dev. Biol. 118:28-41.
37. Russell, S. M., N. Tayebi, H. Nakajima, M. C. Riedy, J. L. Roberts, M. J. Aman, T.-S. Migone, M. Noguchi, M. L. Markert, R. H. Buckley, J. J. O'Shea, and W. L. Leonard. 1995. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800.
38. Sadowski, H. B., and M. Z. Gilman. 1993. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature 362:79-83.
39. Schindler, C., and J. E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the Jak-Stat pathway. Annu. Rev. Biochem. 64:621-651.
40. Selden, R. F. 1991. Transfection using DEAE-dextran, p. 9.2.1-9.2.6. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Wiley Interscience, New York, N.Y.
41. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted stat6 gene. Nature 380:630-633.
42. Summers, M. D., and G. E. Smith. 1987. A manual of methods for baculo-virus vector and insect cell culture procedures. Texas Agricultural Station. College Station.
43. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signaling. Nature 380:627-630.
44. Thomis, D. C., C. B. Gurniak, E. Tivol, A. H. Sharpe, and L. J. Berg. 1995. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270:794-797.
45. Velazquez, L., M. Fellous, G. R. Stark, and S. Pellegrini. 1992. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313-322.
46. Velazquez, L., K. E. Mogensen, G. Barbieri, M. Fellous, G. Uze, and S. Pellegrini. 1995. Distinct domains of the protein tyrosine kinase tyk2 required for binding of interferon-α/β and for signal transduction. J. Biol. Chem. 270:3327-3334.
47. Wakao, H., F. Gouilleux, and B. Groner. 1994. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 13:2182-2191.
48. Winston, L. A., and T. Hunter. 1995. JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J. Biol. Chem. 270:30837-30840.
49. Witthuhn, B., F. W. Quelle, O. Silvennoinen, T. Yi, B. Tang, O. Miura, and J. N. Ible. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following EPO stimulation. Cell 74: 227-236.
50. Yan, R., S. Small, C. Desplan, C. R. Dearolf, and J. E. Darnell. 1996. Identification of a stat gene that functions in Drosophila development. Cell 84:421-430.
51. Yan, R., H. Luo, J. E. Darnell, and C. R. Dearolf. 1996. A JAK-STAT pathway regulates wing vein formation in Drysophila. Proc. Natl. Acad. Sci. USA 93:5842-5847.
52. Zhuang, H., S. V. Patel, T. He, Z. Niu, and D. M. Wojchowski. 1994. Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem. Biophys. Res. Commun. 204: 278-283.
53. K-pn, a homologue of the metastasis suppressor gene nm23, suppresses the Tum-l haematopoietic oncogene. Nat. Genet. 4:195-201.